PatientsVille.com Logo

Increased and Mucinex

PatientsVille

Increased Symptoms and Causes

The appendix is a small, tube-like organ attached to the first part of the large intestine. It is located in the lower right part of the abdomen. It has no known function. A blockage inside of the appendix causes appendicitis. The blockage leads to Increased pressure, problems with blood flow, and inflammation. If the blockage is not treated, the appendix can burst and spread infection into the abdomen. This causes a condition called peritonitis.

The main symptom is pain in the abdomen, often on the right side. It is usually sudden and gets worse over time. Other symptoms may include

  • Swelling in the abdomen
  • Loss of appetite
  • Nausea and vomiting
  • Constipation or diarrhea
  • Inability to pass gas
  • Low fever

Not everyone with appendicitis has all these symptoms.

Appendicitis is a medical emergency. Treatment almost always involves removing the appendix. Anyone can get appendicitis, but it is more common among people 10 to 30 years old.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for increased

increased treatment research studies

Mucinex clinical trials, surveys and public health registries


Find Drug Side Effect reports



Mucinex Side Effects

Dizziness (322)
Blood Pressure Increased (225)
Headache (181)
Epistaxis (169)
Nausea (162)
Feeling Abnormal (157)
Heart Rate Increased (127)
Diarrhoea (124)
Hallucination (119)
Insomnia (113)
Dyspnoea (109)
Anxiety (108)
Vomiting (84)
Hypertension (73)
Confusional State (68)
Loss Of Consciousness (63)
Haemoptysis (62)
Tremor (55)
Asthenia (53)
Somnolence (46)
Palpitations (43)
Nervousness (41)
Off Label Use (38)
Hyperhidrosis (35)
Disorientation (35)
Urticaria (34)
Fatigue (34)
Abdominal Pain Upper (32)
Accidental Overdose (30)
Overdose (30)
Chest Pain (29)
Convulsion (28)
Cough (28)
Malaise (25)
Feeling Jittery (24)
Syncope (24)
Hypoaesthesia (24)
Lip Swelling (23)
Lethargy (23)
Psychomotor Hyperactivity (22)
Hypersensitivity (22)
Pharyngeal Oedema (22)
Faeces Discoloured (22)
Agitation (22)
Rash (21)
Chest Discomfort (21)
Unevaluable Event (21)
Vision Blurred (21)
Mucosal Haemorrhage (20)
Dysphagia (20)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I took Mucinex DM 1200mg once at 10:30 pm and again at 10:30 am. By noon I wasnt functional at all, I had severe loss of focus, my eyes were dilated, and I was really slow, on top of the usual side effects of being jittery and nauseous. Since

I am having a horrible experience with this drug (Mucinex DM). Certainly it 'loosens mucous' in my bronchial tubes, but it then seems to pump fluids into my lungs at an alarming rate, and I must force agressive

I took mucinex dm maximum strength last night around 2:30 am because i couldn't stop coughing and it the cough wasn't letting me go to sleep..someone from the pharmacy at walgreens recommended it..anyways around 6:30 am i started

<span style='color: #808080;'>I would like to share my experience with anyone that can read this.I have Fibromyalgia.I use guaifenesin to expell all the calcium phosphates from my body.I have been taking it over 6 years.Mucinex pretty much has

<span style='color: #808080;'>My ALT is 66. What does that mean?

I started taking MuccinexD yesterday. I didnt know if it was just me being sick or if it was the medicine until I called the on call doctor. I got bad diarreah, and everytime I got up I felt dizzy and almost outside myself. It

Liquid Poop... took just ONE pill at 1:00pm and on the toilet 4 times already and it has only been 2 hours since i took it... i sure hope this goes away. Well i know the bottle is cause I'm not taking it again. It's fu

<strong>I have COPD/emphysema... and a few months ago I used Mucinex to try and help clear me up but, I didn't know at that time..it only made it worse. I was taken to ER. Just last week I started having trouble breathing and coughin up the gar

1st time taking Musinex DM. On a red eye flight. Worst experience ever. About 2 hrs. of taking this Musinex DM I woke up with tingling all over my body, sweating profusely, nausa, and can't think clean.. It lasted around 9 hours. I prayed for this da

38 yr old female within a few hours after taking mucinex d i began feeling frusterated, impatient,aggitated, short tempered, and felt overall not myself. i had to put my 1 and 3 year olds to bed early to avoid them dealing with m

I have been put on Molipaxin 3 weeks ago, I have dry mouth, hair loss and my panic attacks were showing no signs of improvement. Dr increased it to 100mg and put me onto Lamictin. I am not bi polar nor epileptic. My disorder ist algora phoebia. I a

Side effects I have from Nadolol are confusion, dizziness, lightheaded, increased depression and anxiety, and mild nausea.

Have taken hydrea for a year because my spleen had increased in size. I have noticed increased loss of memory and some confusion for the past couple of months. I take 500 mg every other day and 1000 mg every other day.

after taking my medicine .i felt abnormal taste in mouth and my bilurubin level was increased.

Unresponsive to 5mg/kg q 8wks; increased to 10mg/kg q6wks. After 3 doses at that strength noted fatigue, occasional night sweats, joint aches, sudden onset of chest pain and dyspnea (pleurisy, small pleuraleffusion) Had just taper

<span style='color: #808080;'>Took Diprophos for rheumatoid arthritis. Side effects: insomnia for 2 nights, perspiring during night, redness in face. Increased need to urinate.

Since starting champix i have experienced severral side effects including: -increased urination -lower back pain -extreme fatigue -mood swings -decrease in sex drive

<strong>I took 2 capsules at 7.20m after having breakfast and started feeling side effects at 8.25am. It started with increased temperature, abnormal levels of perspiration, dizziness and severe nausea. </strong

1+ years on this carvedilol 12.5 once a day then increased to 2x per day. Asthma symptoms, tightness in the chest, confusion, dizziness, some heart palpitation, ringing in the ears, disorientation (the worst). 57 yr old male, reasonable health for a

10 years on effexor, weight gain of 20 lbs last 5 years when increased to 300mg., no change in cal or exercise, since getting older realized needed fewre calories so tried to reduce like always could wirhWW and exercise, no success, couldn'

Increased Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity
Condition: Menstrual Irregularity
Intervention: Behavioral: Increased calorie intake
Outcome Measures: Reproductive hormones;   Metabolic hormones;   Metabolic bone markers;   Bone mineral density;   Eating Disorder Inventory-2 (EDI-2);   Three Factor Eating Questionnaire
2 Recruiting A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
Condition: Castration Resistant Prostate Cancer
Interventions: Drug: Abiraterone Acetate;   Drug: Prednisone
Outcome Measures: PSA response proportion to Increased-dose Abiraterone Acetate for patients who experienced disease progression following standard dose Abiraterone Acetate therapy;   Safety of treatment;   Clinical benefit (time to PSA progression and progression free survival) for patients treated with Increased dose Abiraterone Acetate;   Serum concentration of Abiraterone Acetate;   Circulating androgen levels
3 Recruiting Optimizing Kidney Transplant Informed Consent
Condition: End-stage Kidney Disease
Intervention: Behavioral: Inform Me: web-based education tool
Outcome Measures: Knowledge of Increased risk donor kidney transplants;   Willingness to accept an Increased risk donor kidney transplant
4 Recruiting Community-based Interventions to Increase HIV Testing and HIV Care Utilization
Condition: HIV
Interventions: Other: HIV testing;   Other: standard of HIV care;   Behavioral: HIV care utilization
Outcome Measures: Increased HIV care utilization;   Increased HIV testing among populations at risk for HIV
5 Recruiting Manual Therapy and Augmented Exercise for Neck Pain
Condition: Neck Pain
Interventions: Other: Augmented Exercise and Manual Therapy;   Other: General Exercise and Manual Therapy
Outcome Measures: Change in Neck Disability Index (NDI);   Change in Numeric Pain Rating Scale (NPRS);   Change in Self Reported Activity Scale (SAA);   Change in Pressure Pain Threshold (PPT);   Change in Vibratory Measure
6 Not yet recruiting IPHAAB-study Influence of Physical Activity on Atherosclerosis Biomarkers
Condition: Influence of 8 Months of Increased Physical Activity Workload on Osteoprotegerin Levels
Intervention: Other: Increased sports workload
Outcome Measures: Change from baseline osteoprotegerin level to osteopontin levels after 8 months of Increased physical activity workload;   Change from baseline Progerin, Myeloid-related peptide 8 and 14, Angiopoietin-like protein 2, Cathepsin S and K, Cystatin C and Placental growth factor level to levels after 8 months of Increased physical activity workload
7 Recruiting Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer
Condition: Women at Increased Risk for Developing Breast Carcinoma
Intervention: Other: Mammography (CESM) and MRI
Outcome Measure: compare the sensitivity and specificity CESM
8 Not yet recruiting Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence
Condition: Atrial Fibrillation
Interventions: Procedure: Wide area circumferential catheter ablation;   Procedure: Augmented- wide area circumferential ablation procedure
Outcome Measures: Recurrence of any ECG documented AF, AFl or AT;   repeat catheter ablation procedure;   ECG documented AF;   emergency department visits or hospitalizations;   procedure related complications;   Quality of Life
9 Recruiting FITT Exercise Counseling With Interactive Accelerometry and Physical Activity in Adolescents at Increased Risk of Early Cardiovascular Disease: A Pilot Study
Condition: Coronary Artery Disease Risk High
Intervention: Device: BodyMedia
Outcome Measures: Increase Physical Activity;   Improve risk factors
10 Recruiting Phenotype Depression Study
Condition: Major Depressive Disorder
Intervention:
Outcome Measures: We are using clinician administered and self report psychiatric measurements to compare relevant symptom domains in patients with major depression and Increased inflammation versus patients with major depression without Increased inflammation.;   We are measuring immune markers for the identification of relevant immunologic patterns of activation in patients with major depression and Increased inflammation versus patients with major depression without Increased inflammation.
11 Recruiting Correlates and Consequences of Increased Immune Activation in Injection Drug Users
Condition: Healthy Volunteers
Intervention: Procedure: Sigmoidoscopy with biopsy
Outcome Measures: Examine the behavioral and immunological correlates of Increased immune activation in active and former injection drug users (IDUs) in blood and tissue.;   Determine the mechanisms of Increased immune activation associated with active IDU using a systems biology approach.
12 Unknown  Thyroid Hormone Dose Adjustment in Pregnancy
Conditions: Pregnancy;   Hypothyroidism
Interventions: Drug: Anticipatory dose increase of levothyroxine;   Drug: levothyroxine
Outcome Measures: proportion of patients in each treatment arm euthyroid through gestation;   the proportion of patients in each arm who required, and the gestation week at which, levothyroxine dose adjustments (either Increased or decreased) occurred to maintain a euthyroid state;   Determination of the necessary frequency of serum evaluation of TSH during the first half of gestation.
13 Not yet recruiting Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow
Conditions: Heart Septal Defects, Ventricular;   Atrioventricular Septal Defect
Intervention: Drug: IV L-carnitine
Outcome Measures: Blood carnitine level (free, total, and acylcarnitine);   Bioavailable nitric oxide;   Plasma levels of superoxide;   Carnitine Palmityl Transporter-1 and -2 expression;   Cardiopulmonary bypass;   Echocardiographic measurements;   Blood BNP level;   Duration of mechanical ventilation;   Vasopressor infusions;   Need for inhaled nitric oxide;   Incidence of low cardiac output syndrome;   Need for extracorporeal life support;   Plasma H202 levels;   Aortic cross clamp times
14 Recruiting Increased Cefazolin During Cesarean Delivery in Obese Population
Conditions: Obesity;   Obesity, Morbid;   Pregnancy;   Infection; Cesarean Section
Intervention: Drug: Cefazolin
Outcome Measure: Achievement of minimal inhibitory concentrations within adipose and serum sampled at time of cesarean delivery
15 Recruiting Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke
Condition: Stroke
Interventions: Behavioral: Cognitive-Oriented Strategy Augmented Rehabilitation (COSTAR);   Behavioral: Task Specific Training (TST)
Outcome Measures: Canadian Occupational Performance Measure (COPM);   Performance Quality Rating Scale (PQRS);   Reintegration to Normal Living Index (RNLI);   Patient Reported Outcomes Measurement System (PROMIS-57);   Stroke Impact Scale (SIS);   Patient Health Questionnaire (PHQ-9);   Self-Efficacy Gauge (SEG);   Activity Card Sort (ACS)
16 Not yet recruiting HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention
Condition: Risk Reduction Behavior
Interventions: Behavioral: HOLA en Grupos;   Behavioral: General Health intervention (comparison intervention )
Outcome Measures: Increased self-reported consistent use of condoms during sexual intercourse;   Increased self-reported use of HIV and sexually transmitted disease (STD) counseling, testing, and treatment services
17 Recruiting Effect of Gain on Closed-Loop Insulin
Condition: Type 1 Diabetes
Interventions: Device: Gain (reference);   Device: Gain decreased by a factor 0.8;   Device: Gain Increased by a factor 1.33
Outcome Measures: Glucose Area Under the Curve (AUC) Breakfast;   Peak and nadir postprandial glucose concentration
18 Recruiting Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension
Condition: Intradialytic Hypertension
Intervention: Drug: Carvedilol vs. Prazosin
Outcome Measures: Ratio of Extracellular Body Water to Total Body Water;   Change in Endothelin-1 from pre to post dialysis
19 Recruiting Impact of Increased Water Intake in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention: Dietary Supplement: Hydration
Outcome Measures: Renal decline;   albumin to creatinine ratio;   Rapid renal decline
20 Recruiting Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Radiation: 3-D Ultrasound;   Drug: recombinant human chorionic gonadotropin;   Drug: Recombinant follicle stimulating hormone;   Drug: Dexamethasone;   Drug: Adrenocorticotropin;   Drug: Glucose
Outcome Measures: 17-hydroxyprogesterone responses to hCG with and without FSH in PCOS women and normal controls;   Follicle count on 3-D Ultrasound in PCOS women and normal controls;   Adrenal androgen response to ACTH in PCOS women and normal controls;   17-hydroxyprogesterone response to hCG in the setting of reduced insulin secretion in PCOS women